HQ Function

Served as the main center for Vtesse's clinical development programs, regulatory affairs, scientific research management, and corporate operations focused on rare diseases.

Notable Features:

As a clinical-stage company incubated within a larger development group's facilities, its headquarters likely comprised modern office and lab-support spaces designed for managing clinical trials and R&D collaborations, rather than large-scale manufacturing capabilities.

Work Culture:

The work culture at Vtesse was likely driven by a strong patient-centric mission, typical of rare disease biotechs. It would have emphasized scientific innovation, collaboration, and a sense of urgency to address critical unmet medical needs for NPC1 patients and their families.

HQ Significance:

The Gaithersburg, Maryland location provided Vtesse with proximity to key U.S. regulatory agencies like the FDA, a rich talent pool in biotechnology, and a network of research institutions, which was advantageous for its drug development efforts.

Values Reflected in HQ: The headquarters would have reflected Vtesse's commitment to advancing science for rare diseases, fostering innovation, and maintaining a lean, focused operational model to expedite development.

Location:

During its operational phase, Vtesse's global presence was primarily defined by its international Phase 2b/3 clinical trial program for VTS-270. The company collaborated with leading medical centers and investigators in multiple countries, including the United States, United Kingdom, Germany, France, Spain, Turkey, and Australia, to enroll and treat patients with Niemann-Pick Type C1 disease. This global reach was essential for studying a rare disease with a dispersed patient population.

Street Address:

200 Orchard Ridge Drive, Suite 150

City:

Gaithersburg

State/Province:

Maryland

Country:

USA